Article Information
History
- May 27, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Patricia X. Marques, PhDa,
- Handan Wand, PhDb,
- Melissa Nandy, MScc,
- Chun Tan, PhDa,
- Huizhong Shou, BSa,
- Mishka Terplan, PhDd,
- Katrina Mark, MDe,
- Rebecca M. Brotman, PhDc,
- David P. Wilson, PhDf,
- Jacques Ravel, PhDg,c,
- Ru-ching Hsia, PhDh and
- Patrik M. Bavoil, PhDa,*
- aDepts of Microbial Pathogenesis, University of Maryland, Baltimore, Maryland, USA
- bThe Kirby Institute, University of New South Wales, Sydney, Australia
- cInstitute for Genome Science, University of Maryland, Baltimore, Maryland, USA
- dDepts of Obstetrics & Gynecology, University of Maryland, Baltimore, Maryland, USA
- eDepts of Pediatrics, University of Maryland, Baltimore, Maryland, USA
- fThe Burnet Institute, Melbourne, Australia
- gDepts of Microbiology and Immunology, University of Maryland, Baltimore, Maryland, USA
- hDepts of Electron Microscopy Core Imaging Facility, University of Maryland, Baltimore, Maryland, USA
- ↵*Corresponding author:
Patrik M Bavoil, Dept of Microbial Pathogenesis, University of Maryland School of Dentistry, 650 W. Baltimore St., Baltimore, MD 21201. Tel: 410 706 6789; Fax: 410 706 0865; e-mail: pbavoil{at}umaryland.edu.
Posted May 27, 2021.
Serum antibodies to surface proteins of Chlamydia trachomatis as candidate biomarkers of disease: Results from the Baltimore Chlamydia Adolescent/Young Adult Reproductive Management (CHARM) cohort
